Home › Funds › Krensavage Asset Management, LLC › ENTA
Krensavage Asset Management, LLC position in ENTA
ENANTA PHARMACEUTICALS INC COM · Health Care
Krensavage Asset Management, LLC reported holding 2,866,138 shares of ENTA (ENANTA PHARMACEUTICALS INC COM) in its Q2 2026 13F filing — a position valued at US$41.8M, representing 15.88% of its reported portfolio and ranking #1 among its reported holdings. Krensavage Asset Management, LLC has disclosed ENTA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Krensavage Asset Management, LLC's ENTA position evolved
Krensavage Asset Management, LLC first disclosed a stake in ENTA in Q3 2023 at 735,103 shares (US$8.2M). The position peaked in Q4 2025 at 2,766,390 shares, worth US$43.6M. Across 12 filings, Krensavage Asset Management, LLC increased the stake 7 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 2,866,138 shares valued at US$41.8M. Notable position changes include a 51% increase in Q1 2024 (shares fell 26% over the following quarter), a 41% increase in Q4 2024 (shares fell 4% over the following quarter), a 31% increase in Q4 2025 (shares fell 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 735.10K | $8.21M | New |
| Q4 2023 | 742.82K | $6.99M | Add |
| Q1 2024 | 1.12M | $19.64M | Add |
| Q2 2024 | 1.25M | $16.23M | Add |
| Q3 2024 | 1.50M | $15.52M | Add |
| Q4 2024 | 2.12M | $12.18M | Add |
| Q1 2025 | 2.12M | $11.68M | Hold |
| Q2 2025 | 2.11M | $15.98M | Hold |
| Q3 2025 | 2.11M | $25.31M | Hold |
| Q4 2025 | 2.77M | $43.63M | Add |
| Q1 2026 | 2.87M | $36.20M | Add |
| Q2 2026 | 2.87M | $41.79M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ENTA and 13F data
ENTA (ENANTA PHARMACEUTICALS INC COM) is a Health Care company. 28 other funds we track also report a position in ENTA — the largest reported positions include Farallon Capital Management (US$35.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$35.3M), ADAR1 Capital Management, LLC (US$19.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENTA
- Farallon Capital Management 2.42M sh · $35.26M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.42M sh · $35.26M · Q2 2026
- ADAR1 Capital Management, LLC 1.34M sh · $19.60M · Q2 2026
- Spruce Street Capital LP 1.09M sh · $15.87M · Q2 2026
More on Krensavage Asset Management, LLC
FAQ
How long has Krensavage Asset Management, LLC held ENTA?
Krensavage Asset Management, LLC has disclosed ENTA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Krensavage Asset Management, LLC's current position in ENTA?
As of Q2 2026, Krensavage Asset Management, LLC holds 2.87M shares of ENTA (ENANTA PHARMACEUTICALS INC COM), valued at $41.79M, representing 15.88% of its reported portfolio and ranking #1.
Has Krensavage Asset Management, LLC been buying or selling ENTA?
In the latest 13F filing (Q2 2026), Krensavage Asset Management, LLC held unchanged its position in ENTA. The position peaked in Q4 2025 at 2.77M shares.
Which other funds hold ENTA?
Other major institutional holders of ENTA include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., ADAR1 Capital Management, LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.